Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cosyntropin and Vigabatrin for Infantile Spasms
NCT03347526Phase 3Suspended
- Sponsor
- University of Colorado Denver
- Start
- Apr 2018
- Primary completion
- Jun 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tetracosactide hexaacetate in infantile epileptic spasms syndrome (IESS), sponsored by University of Colorado Denver. Started Apr 2018; status: suspended.
02
Drugs
tetracosactide hexaacetate
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT03347526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03347526.